Earnings ·
GE HealthCare reports Q3 EPS of $1.36, raises full-year guidance
GEHCGE HealthCare Technologies Inc.
GE HealthCare reported third-quarter 2026 revenue of $5.5 billion, up 7.2% year-over-year, with diluted earnings per share of $1.36, a 39.1% increase from the prior year period. The company raised its full-year 2026 adjusted EPS guidance to $4.95–$5.05 and organic revenue growth expectations to approximately 4.0%. Additionally, Jeannette Bankes resigned as President and CEO of the Patient Care Solutions segment effective November 15, 2026. GE HealthCare Technologies Inc. operates in the medical technology industry, providing diagnostic imaging, patient care solutions, and pharmaceutical diagnostics.